Hemodynamic consequences of multitherapy pretreatment in experimental endotoxemia.
Pillgram-Larsen
J
J
Ruud
T E
TE
Stadaas
J O
JO
Aasen
A O
AO
D000818:Animals; D004359:Drug Therapy, Combination; D004731:Endotoxins / Q000097:blood*; D004926:Escherichia coli; D006439:Hemodynamics / Q000187:drug effects*; D007650:Ketanserin / Q000627:therapeutic use; D008070:Lipopolysaccharides; D008775:Methylprednisolone / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D010100:Oxygen / Q000097:blood; D011398:Promethazine / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D011652:Pulmonary Circulation / Q000187:drug effects; D012772:Shock, Septic / Q000097:blood / Q000188:drug therapy*; D013552:Swine
D004731:Endotoxins; D008070:Lipopolysaccharides; D011480:Protease Inhibitors; C036757:lipopolysaccharide B; D009270:Naloxone; D007650:Ketanserin; D011398:Promethazine; D010100:Oxygen; D008775:Methylprednisolone